ES2106188T3 - Analogos de bombesina. - Google Patents

Analogos de bombesina.

Info

Publication number
ES2106188T3
ES2106188T3 ES92913859T ES92913859T ES2106188T3 ES 2106188 T3 ES2106188 T3 ES 2106188T3 ES 92913859 T ES92913859 T ES 92913859T ES 92913859 T ES92913859 T ES 92913859T ES 2106188 T3 ES2106188 T3 ES 2106188T3
Authority
ES
Spain
Prior art keywords
bombesin
derivatives
antagonist
methyl
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92913859T
Other languages
English (en)
Inventor
Judson V Edwards
Bradford O Fanger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2106188T3 publication Critical patent/ES2106188T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086—Bombesin; Related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Silicon Polymers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE PRESENTAN AGONISTAS Y ANTAGONISTAS DE BOMBESINA QUE SON DERIVADOS DE BOMBESINA QUE SE DA NATURALMENTE QUE POSEE UN ENLACE DE SULFURO DE METILO O UNO DE AMIDA DE METILO QUE CONECTA LOS DOS AMINOACIDOS SOBRE EL EXTREMO TERMINAL CARBOXI. LAS ACTIVIDADES AGONISTAS Y ANTAGONISTAS SE CONFIRMAN UTILIZANDO ENSAYOS BIOQUIMICOS Y DE ENLACE COMPETITIVOS CONVENCIONALES ASI COMO PRUEBAS FISIOLOGICAS CONVENCIONALES Y EL USO DE ESTOS DERIVADOS EN UNA VARIEDAD DE CONDICIONES. EL USO DE ESTOS PEPTIDOS COMPRENDE LA SIMULACION O LA ANTAGONIZACION DEL CRECIMIENTO DE TEJIDOS, ESPECIALMENTE DEL PULMON, Y UN MEDIO PARA EFECTUAR EL TRATAMIENTO DE TRASTORNOS DIGESTIVOS. EL TRATAMIENTO CONSISTE EN ADMINISTRAR A UN PACIENTE NECESITADO DE ELLO, UNA CANTIDAD EFECTIVA DE UN ANALOGO DE BOMBESINA.
ES92913859T 1991-05-23 1992-04-21 Analogos de bombesina. Expired - Lifetime ES2106188T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70486391A 1991-05-23 1991-05-23

Publications (1)

Publication Number Publication Date
ES2106188T3 true ES2106188T3 (es) 1997-11-01

Family

ID=24831155

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92913859T Expired - Lifetime ES2106188T3 (es) 1991-05-23 1992-04-21 Analogos de bombesina.

Country Status (11)

Country Link
US (1) US5428019A (es)
EP (1) EP0585397B1 (es)
JP (1) JP3350701B2 (es)
AT (1) ATE156492T1 (es)
AU (1) AU659659B2 (es)
CA (1) CA2109322C (es)
DE (1) DE69221486T2 (es)
DK (1) DK0585397T3 (es)
ES (1) ES2106188T3 (es)
GR (1) GR3025003T3 (es)
WO (1) WO1992020707A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723578A (en) * 1987-09-24 1998-03-03 The Administrators Of Tulane Educational Fund Peptide analogs of bombesin
US5877277A (en) 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
CA2042027A1 (en) * 1989-09-15 1991-03-16 Arthur E. Bogden Treatment of colon cancer
US5650395A (en) * 1995-03-13 1997-07-22 Hurel; Steven Treatment of pulmonary hypertension
US5786335A (en) * 1995-11-06 1998-07-28 Warner-Lambert Company Sulfhydryl containing peptides for treating vascular disease
US7078413B2 (en) 1996-04-19 2006-07-18 Wisconsin Alumni Research Foundation Compositions and methods of use for a bombesin peptide
US6989371B1 (en) 1996-08-16 2006-01-24 Dabur Research Foundation Bombesin analogs for treatment of cancer
US5861532A (en) * 1997-03-04 1999-01-19 Chiron Corporation Solid-phase synthesis of N-alkyl amides
DE69840647D1 (de) * 1997-04-22 2009-04-23 Curator Of The University Of M Konjugate aus peptiden, die liganden von gastrinrezeptoren sind
US7060247B2 (en) * 1997-04-22 2006-06-13 The Curators Of The University Of Missouri Gastrin receptor-avid peptide conjugates
WO1999013738A1 (en) * 1997-09-16 1999-03-25 Societe Des Produits Nestle S.A. Organ specific nutrition
US7850947B2 (en) 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
CA2512310C (en) * 2003-01-13 2012-09-25 Bracco Imaging S.P.A. Improved linkers for radiopharmaceutical compounds
US8420050B2 (en) * 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7226577B2 (en) * 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
US7922998B2 (en) * 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7611692B2 (en) 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US20060239923A1 (en) * 2003-01-13 2006-10-26 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
AU2004220104A1 (en) * 2003-03-10 2004-09-23 Biogen Idec Inc. Thiol-mediated drug attachment to targeting peptides
CN111500612A (zh) * 2020-03-30 2020-08-07 扬州大学 一种可溶性猪胃泌素释放肽融合蛋白表达载体及其应用
CN116333041A (zh) * 2023-04-10 2023-06-27 湖南中晟全肽生化有限公司 一种激活grp受体的多肽化合物及其用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592552A (en) * 1976-12-10 1981-07-08 Inst Nat Sante Rech Med Pseudopeptides used as medicaments
US4631270A (en) * 1978-11-20 1986-12-23 Research Corporation Therapeutically useful pseudopeptides, compositions containing the same and methods of preparation and use
ATE16495T1 (de) * 1981-06-22 1985-11-15 Ici Plc Peptide und pseudopeptide, die zwei substituenten am n-terminus aufweisen.
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
JP2795449B2 (ja) * 1987-09-24 1998-09-10 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 治療用ペプチド
US5047502A (en) * 1987-10-23 1991-09-10 Merck And Co., Inc. Gastrin releasing peptide antagonist
EP0313158A3 (en) * 1987-10-23 1990-08-22 Merck & Co. Inc. Gastrin releasing peptide antagonist
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
GB8806644D0 (en) * 1988-03-21 1988-04-20 Imp Cancer Res Tech Neuropeptide antagonists
GB8808768D0 (en) * 1988-04-14 1988-05-18 Erba Carlo Spa Peptide ligands for bombesin receptors
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds
ZA894533B (en) * 1988-06-20 1990-03-28 Merrell Dow Pharma Neurokinin a antogonists
GR1000608B (el) * 1988-07-21 1992-08-31 Erba Carlo Spa Μεθοδος για την παρασκευη ανταγωνιστων bombesin.
MC2144A1 (fr) * 1988-10-14 1992-02-19 Univ Tulane Peptides therapeutiques
US5028692A (en) * 1989-04-25 1991-07-02 Merck & Co., Inc. Gastrin releasing peptide antagonist
AU6610390A (en) * 1989-11-06 1991-05-31 Farmitalia Carlo Erba S.R.L. Reduced irreversible bombesin antagonists
NZ236114A (en) * 1989-11-22 1993-04-28 Merrell Dow Pharma Peptide antagonists of bombesin and of gastrin releasing peptide, and pharmaceutical compositions

Also Published As

Publication number Publication date
ATE156492T1 (de) 1997-08-15
EP0585397A1 (en) 1994-03-09
AU2184092A (en) 1992-12-30
WO1992020707A1 (en) 1992-11-26
EP0585397B1 (en) 1997-08-06
US5428019A (en) 1995-06-27
GR3025003T3 (en) 1998-01-30
DK0585397T3 (da) 1997-08-25
DE69221486D1 (de) 1997-09-11
AU659659B2 (en) 1995-05-25
DE69221486T2 (de) 1998-03-19
CA2109322A1 (en) 1992-11-24
JP3350701B2 (ja) 2002-11-25
CA2109322C (en) 2002-11-05
JPH06508126A (ja) 1994-09-14

Similar Documents

Publication Publication Date Title
ES2106188T3 (es) Analogos de bombesina.
LU91857I2 (fr) Abarelix, optionnellement sous forme de sel pharmaceutiquement acceptable
SE8703938L (sv) Peptidderivat
DE69434181D1 (de) Therapeutische Peptid Derivate
MXPA05002991A (es) Analogos de ghrh.
AU3576597A (en) Endoderm, cardiac and neural inducing factors
MX9703642A (es) Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana.
KR880012641A (ko) 아미노산 유도체
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
NO942919L (no) Fenylalaninanaloger av bombesin
NZ236114A (en) Peptide antagonists of bombesin and of gastrin releasing peptide, and pharmaceutical compositions
MXPA04004826A (es) Antagonista del receptor de quimioquinas y metodos para su uso.
CA2022740A1 (en) Cyclic neurokinin a antagonists
NO894720L (no) Farmasoeytisk aktivt protein.
BR9911756A (pt) Composto, uso de um secretagogo do hormÈnio do crescimento ou um seu sal farmaceuticamente aceitável, composição farmacêutica, método para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero, e, uso de um composto
WO2002007676A3 (en) Compounds having affinity for the granulocyte-colony stimulating factor receptor (g-csfr)
EP0248231A3 (en) Pharmacologically active peptides
DE3361591D1 (en) Polypeptides with an antagonistic activity on substance p, process for their preparation, their use and process for the purification of polypeptides
EP0177826A3 (de) Arzneimittel und Diagnostikum mit Wachstumshormon-Releasingfaktor-Wirkung
MY102979A (en) Peptide derivatives
RU93058426A (ru) Антогонист галанина, способ его получения, пептид, фармацевтический состав и способ лечения
HUP0000271A2 (en) Use of glucagon-like peptide-1 (glp-1) or analogs to abolish catabolic changes after surgery

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 585397

Country of ref document: ES